Variant report

Variant	nsv963705
Chromosome Location	chr2:113379400-113381483
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:96)
CpG islands
(count:122)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:96 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:113380136-113380406	K562	blood:	n/a	n/a
2	ATF1	chr2:113380074-113380408	K562	blood:	n/a	n/a
3	BHLHE40	chr2:113380122-113380389	K562	blood:	n/a	n/a
4	CCNT2	chr2:113379990-113380381	K562	blood:	n/a	n/a
5	CEBPB	chr2:113380097-113380473	K562	blood:	n/a	chr2:113380319-113380330
6	CEBPB	chr2:113380145-113380482	K562	blood:	n/a	chr2:113380319-113380330
7	CEBPB	chr2:113379456-113379658	IMR90	lung:	n/a	n/a
8	CEBPB	chr2:113380154-113380377	K562	blood:	n/a	chr2:113380319-113380330
9	CEBPB	chr2:113380012-113380505	IMR90	lung:	n/a	chr2:113380319-113380330
10	CEBPB	chr2:113380063-113380565	A549	lung:	n/a	chr2:113380319-113380330
11	CEBPB	chr2:113380008-113380508	Hela-S3	cervix:	n/a	chr2:113380319-113380330
12	CEBPB	chr2:113380203-113380415	HepG2	liver:	n/a	chr2:113380319-113380330
13	CEBPB	chr2:113380138-113380452	A549	lung:	n/a	chr2:113380319-113380330
14	CEBPD	chr2:113380010-113380533	K562	blood:	n/a	n/a
15	CEBPD	chr2:113379999-113380423	K562	blood:	n/a	n/a
16	CHD2	chr2:113380035-113380399	Hela-S3	cervix:	n/a	n/a
17	E2F4	chr2:113379770-113380401	MCF10A-Er-Src	breast:	n/a	n/a
18	EP300	chr2:113379937-113380381	SK-N-SH_RA	brain:	n/a	chr2:113380363-113380377
19	EP300	chr2:113380083-113380464	K562	blood:	n/a	chr2:113380363-113380377
20	EP300	chr2:113380042-113380370	SK-N-SH_RA	brain:	n/a	n/a
21	EP300	chr2:113379984-113380487	Hela-S3	cervix:	n/a	chr2:113380363-113380377
22	EP300	chr2:113379817-113380650	SK-N-SH	brain:	n/a	chr2:113380363-113380377
23	FOS	chr2:113379459-113380478	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr2:113381461-113382455	MCF10A-Er-Src	breast:	n/a	chr2:113382148-113382156 chr2:113382145-113382154 chr2:113382143-113382155 chr2:113382143-113382154
25	FOS	chr2:113380031-113380462	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr2:113379859-113380444	MCF10A-Er-Src	breast:	n/a	n/a
27	FOS	chr2:113381463-113382484	MCF10A-Er-Src	breast:	n/a	chr2:113382148-113382156 chr2:113382145-113382154 chr2:113382143-113382155 chr2:113382143-113382154
28	FOS	chr2:113379535-113380460	MCF10A-Er-Src	breast:	n/a	n/a
29	FOSL2	chr2:113379859-113380450	SK-N-SH	brain:	n/a	n/a
30	GATA1	chr2:113380024-113380462	PBDE	blood:	n/a	n/a
31	GATA1	chr2:113379692-113380566	K562	blood:	n/a	n/a
32	GATA2	chr2:113380039-113380371	K562	blood:	n/a	n/a
33	GATA2	chr2:113379285-113380415	HUVEC	blood vessel:	n/a	n/a
34	GATA2	chr2:113379242-113379608	K562	blood:	n/a	n/a
35	GATA3	chr2:113381419-113382508	SK-N-SH	brain:	n/a	n/a
36	GATA3	chr2:113378904-113380703	SK-N-SH	brain:	n/a	n/a
37	GATA3	chr2:113379917-113380662	SK-N-SH	brain:	n/a	n/a
38	GATA3	chr2:113379174-113379871	SK-N-SH	brain:	n/a	n/a
39	GTF2F1	chr2:113379814-113380359	Hela-S3	cervix:	n/a	n/a
40	IRF1	chr2:113380146-113380405	K562	blood:	n/a	n/a
41	JUN	chr2:113380131-113380416	K562	blood:	n/a	n/a
42	JUN	chr2:113379953-113380563	K562	blood:	n/a	n/a
43	JUND	chr2:113379914-113380489	SK-N-SH	brain:	n/a	n/a
44	JUND	chr2:113379876-113380536	SK-N-SH	brain:	n/a	n/a
45	JUND	chr2:113380044-113380432	K562	blood:	n/a	n/a
46	JUND	chr2:113380005-113380443	Hela-S3	cervix:	n/a	n/a
47	MAFF	chr2:113380096-113380346	K562	blood:	n/a	n/a
48	MAFK	chr2:113380081-113380413	IMR90	lung:	n/a	n/a
49	MAFK	chr2:113380120-113380357	K562	blood:	n/a	n/a
50	MAFK	chr2:113380098-113380423	Hela-S3	cervix:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:113379847-113379897	ovcar-3	ovarian:	n/a
2	chr2:113379847-113379897	H1-hESC	embryonic stem cell:	embryo
3	chr2:113379707-113379757	NT2-D1	testis:	n/a
4	chr2:113379707-113379757	ProgFib	skin:	n/a
5	chr2:113379707-113379757	LNCaP	prostate:	n/a
6	chr2:113379707-113379757	ovcar-3	ovarian:	n/a
7	chr2:113379847-113379897	T-47D	breast:	n/a
8	chr2:113379707-113379757	NHDF-neo	bronchial:	n/a
9	chr2:113379847-113379897	PrEC	prostate:	n/a
10	chr2:113379847-113379897	HPAEpiC	pulmonary alveolar:	n/a
11	chr2:113379847-113379897	PFSK-1	brain:	n/a
12	chr2:113379847-113379897	LNCaP	prostate:	n/a
13	chr2:113379847-113379897	ECC-1	luminal epithelium:	n/a
14	chr2:113379707-113379757	HMEC	breast:	n/a
15	chr2:113379707-113379757	H1-hESC	embryonic stem cell:	embryo
16	chr2:113379847-113379897	GM12878	blood:	n/a
17	chr2:113379707-113379757	GM12891	blood:	n/a
18	chr2:113379707-113379757	AG04450	lung:	fetal
19	chr2:113379847-113379897	GM12892	blood:	n/a
20	chr2:113379847-113379897	AG04449	skin:	fetal
21	chr2:113379707-113379757	HRE	kidney:	n/a
22	chr2:113379707-113379757	HepG2	liver:	n/a
23	chr2:113379707-113379757	NH-A	brain:	n/a
24	chr2:113379847-113379897	HEEpiC	esophagus:	n/a
25	chr2:113379707-113379757	HUVEC	blood vessel:	n/a
26	chr2:113379847-113379897	NHBE	bronchial:	n/a
27	chr2:113379707-113379757	AG04449	skin:	fetal
28	chr2:113379707-113379757	NB4	blood:	n/a
29	chr2:113379847-113379897	HNPCEpiC	eye:	n/a
30	chr2:113379707-113379757	GM06990	blood:	n/a
31	chr2:113379847-113379897	MCF10A-Er-Src	breast:	n/a
32	chr2:113379707-113379757	HPAEpiC	pulmonary alveolar:	n/a
33	chr2:113379707-113379757	HCM	heart:	n/a
34	chr2:113379847-113379897	IMR90	lung:	fetal
35	chr2:113379847-113379897	HCM	heart:	n/a
36	chr2:113379707-113379757	AG10803	skin:	n/a
37	chr2:113379707-113379757	Hepatocyte	liver:	n/a
38	chr2:113379707-113379757	AG09319	gingival:	n/a
39	chr2:113379847-113379897	HCF	heart:	n/a
40	chr2:113379847-113379897	HEK293	kidney:	embryo
41	chr2:113379707-113379757	GM19239	blood:	n/a
42	chr2:113379847-113379897	NT2-D1	testis:	n/a
43	chr2:113379847-113379897	AG09309	skin:	n/a
44	chr2:113379707-113379757	HAEpiC	amniotic membrane:	n/a
45	chr2:113379847-113379897	GM06990	blood:	n/a
46	chr2:113379847-113379897	RPTEC	kidney:	n/a
47	chr2:113379707-113379757	HCT-116	colon:	n/a
48	chr2:113379707-113379757	HCPEpiC	choroid plexus:	n/a
49	chr2:113379707-113379757	SKMC	muscle:	n/a
50	chr2:113379707-113379757	Jurkat	blood:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:113379636..113386577-chr2:113398111..113406278,16	MCF-7	breast:
2	chr2:113380970..113385799-chr2:113479613..113484625,8	K562	blood:
3	chr2:113380843..113384962-chr2:113480402..113484110,5	K562	blood:
4	chr2:113344897..113346779-chr2:113377975..113380310,2	MCF-7	breast:
5	chr2:113380240..113386960-chr2:113401832..113406779,10	MCF-7	breast:
6	chr2:113380065..113382456-chr2:113480700..113483703,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000231747	TF binding region
ENSG00000231747	CpG island
ENSG00000237753	chromatin interactions
ENSG00000144136	chromatin interactions
ENSG00000144130	chromatin interactions
ENSG00000243389	chromatin interactions

Extended variants
information (count: 96 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:96 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs553450664	chr2:113379468-113379469	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs572348450	chr2:113379483-113379484	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs17016958	chr2:113379519-113379520	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs554861159	chr2:113379542-113379543	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs180959660	chr2:113379570-113379571	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs148509857	chr2:113379582-113379583	Weak transcription Enhancers Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs563198459	chr2:113379666-113379667	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs185632193	chr2:113379708-113379709	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs545395292	chr2:113379715-113379716	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs566459681	chr2:113379727-113379728	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs558954690	chr2:113379749-113379750	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs528745810	chr2:113379753-113379754	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs6740389	chr2:113379755-113379756	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs142743600	chr2:113379782-113379783	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs530961380	chr2:113379783-113379784	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs551194887	chr2:113379785-113379786	Weak transcription Enhancers Active TSS Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
17	rs78105036	chr2:113379847-113379848	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs530956150	chr2:113379848-113379849	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs539967521	chr2:113379849-113379850	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs139398514	chr2:113379850-113379851	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs566836267	chr2:113379871-113379872	Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs80238522	chr2:113379905-113379906	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs554518855	chr2:113379913-113379914	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs12999361	chr2:113379981-113379982	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs530182593	chr2:113379986-113379987	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs191343979	chr2:113380066-113380067	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs183659403	chr2:113380073-113380074	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs13025131	chr2:113380114-113380115	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs545529101	chr2:113380130-113380131	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs371193043	chr2:113380137-113380138	Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs528374618	chr2:113380201-113380202	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs572724414	chr2:113380255-113380256	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs77518044	chr2:113380268-113380269	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs541812871	chr2:113380269-113380270	Weak transcription Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs562234282	chr2:113380344-113380345	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs1568115	chr2:113380349-113380350	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs1568114	chr2:113380352-113380353	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs78800604	chr2:113380367-113380368	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs571403100	chr2:113380392-113380393	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs372843571	chr2:113380395-113380396	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs531282101	chr2:113380420-113380421	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs78660180	chr2:113380435-113380436	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs2716667	chr2:113380439-113380440	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs376760514	chr2:113380450-113380451	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs13036164	chr2:113380451-113380452	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs530586229	chr2:113380461-113380462	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs137903576	chr2:113380466-113380467	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs66520048	chr2:113380476-113380477	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs374231049	chr2:113380500-113380501	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
50	rs2716666	chr2:113380509-113380510	Weak transcription Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	17483303	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Astrocytoma	22246337	CNVD
Myelofibrosis	22110671	CNVD
Ocular motor apraxia	21572526	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	21549014	CNVD
Idiopathic chronic pancreatitis	21549014	CNVD
Mental retardation	21549014	CNVD
Maculopathy	20981449	CNVD
Nephronophthisis	22470819	CNVD
Colorectal cancer	16912164	CNVD
Ischaemic stroke	16980335	CNVD
Acute myeloid leukemia	18000384	CNVD
Nephronophthisis	17901113	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Cancer	17440070	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:127 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:113348600-113383600	Weak transcription	Brain Cingulate Gyrus	brain
2	chr2:113349000-113384000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
3	chr2:113357800-113384200	Weak transcription	Pancreas	Pancrea
4	chr2:113358000-113384000	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
5	chr2:113370400-113383800	Weak transcription	Fetal Muscle Leg	muscle
6	chr2:113371600-113382000	Weak transcription	Spleen	Spleen
7	chr2:113372200-113379800	Weak transcription	Fetal Muscle Trunk	muscle
8	chr2:113372200-113384200	Weak transcription	Fetal Intestine Small	intestine
9	chr2:113372400-113384000	Weak transcription	Brain Anterior Caudate	brain
10	chr2:113372400-113388600	Weak transcription	Gastric	stomach
11	chr2:113372600-113379800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr2:113372800-113388000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
13	chr2:113373000-113379800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
14	chr2:113373000-113379800	Weak transcription	Skeletal Muscle Male	skeletal muscle
15	chr2:113373000-113383200	Weak transcription	Fetal Brain Female	brain
16	chr2:113373200-113384000	Weak transcription	Brain Germinal Matrix	brain
17	chr2:113376600-113379800	Weak transcription	Primary monocytes fromperipheralblood	blood
18	chr2:113376800-113379600	Weak transcription	Monocytes-CD14+_RO01746	blood
19	chr2:113377400-113384200	Weak transcription	Right Atrium	heart
20	chr2:113377800-113379600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
21	chr2:113378200-113382000	Weak transcription	Adipose Nuclei	Adipose
22	chr2:113378400-113379800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
23	chr2:113378400-113379800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
24	chr2:113378400-113382200	Enhancers	HMEC	breast
25	chr2:113378600-113379400	Enhancers	NHEK	skin
26	chr2:113378600-113379600	Enhancers	Hela-S3	cervix
27	chr2:113378600-113380200	Enhancers	NHDF-Ad	bronchial
28	chr2:113378600-113380400	Enhancers	NHLF	lung
29	chr2:113378600-113381600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
30	chr2:113378800-113379600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr2:113378800-113379600	Enhancers	NH-A	brain
32	chr2:113378800-113379600	Enhancers	Osteobl	bone
33	chr2:113378800-113379800	Weak transcription	Placenta Amnion	Placenta Amnion
34	chr2:113378800-113382000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
35	chr2:113378800-113384000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
36	chr2:113379000-113379600	Enhancers	Muscle Satellite Cultured Cells	--
37	chr2:113379000-113379800	Weak transcription	H9 Cell Line	embryonic stem cell
38	chr2:113379200-113380200	Enhancers	iPS-15b Cell Line	embryonic stem cell
39	chr2:113379400-113380200	Flanking Active TSS	NHEK	skin
40	chr2:113379600-113379800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr2:113379600-113379800	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
42	chr2:113379600-113379800	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
43	chr2:113379600-113379800	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
44	chr2:113379600-113379800	Flanking Active TSS	Placenta	Placenta
45	chr2:113379600-113379800	Active TSS	Monocytes-CD14+_RO01746	blood
46	chr2:113379600-113380000	Flanking Active TSS	Hela-S3	cervix
47	chr2:113379600-113380200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr2:113379600-113380200	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr2:113379600-113380200	Flanking Active TSS	Muscle Satellite Cultured Cells	--
50	chr2:113379600-113380200	Enhancers	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links